Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.62) by 4.84 percent. This is a 20.27 percent increase over losses of $(0.74) per share from the same period last year.
Dollar General Analysts Cut Their Forecasts After Q1 Results
Dollar General Corp (NYSE:DG) reported better-than-expected first-quarter financial results on Thursday. Dollar General reported first-quarter FY24 sales growth…